Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to find the optimal dose of Org 37462 for Japanese females undergoing controlled ovarian stimulation for in vitro fertilization intracytoplasmic sperm injection (IVF-ICSI).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Controlled Ovarian Stimulation

Clinical Trial Details

NCT number	NCT00988260
Study type	Interventional
Source	Organon and Co
Contact
Status	Completed
Phase	Phase 2
Start date	February 3, 2003
Completion date	April 12, 2004

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04122729` - N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS
	Terminated	`NCT03697031` - Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®
	Completed	`NCT03051087` - To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®	Phase 4
	Completed	`NCT01339299` - Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)	Phase 4
	Completed	`NCT03366025` - Progesterone Variation on the Final Day of Oocyte Maturation.
	Completed	`NCT00725491` - A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)	Phase 3
	Completed	`NCT03564509` - A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.	Phase 2
	Completed	`NCT03393780` - Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures
	Completed	`NCT04503707` - Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice
	Withdrawn	`NCT01510054` - Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA	N/A
	Completed	`NCT05499052` - Trial to Assess the Pattern of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation (IVF) or Intracytoplasmic Sperm Injection (ICSI) Procedures in Routine Clinical Practice